Applied Genetic Technologies reported $66.68M in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alimera Sciences ALIM:US $ 47.57M 2.36M
Applied Genetic Technologies AGTC:US $ 66.68M 20.51M
Avrobio Inc AVRO:US $ 146.24M 29.1M
Biogen BIIB:US $ 25081.4M 1467M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Cti Biopharma CTIC:US $ 134.53M 3.1M
Gilead Sciences GILD:US $ 62870M 210M
Insmed INSM:US $ 1.05B 99.96M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Life Technologies LIFE:US $ 96.02M 8.76M
Ophthotech OPHT:US $ 319.76M 32.95M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M